This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Nasal Obstruction in Sleep Apnea Patients Compared to the General Population

This study has been completed.
Sponsor:
Collaborator:
Sorlandet Hospital HF
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01282125
First received: January 18, 2011
Last updated: March 10, 2017
Last verified: March 2017
History of Changes
January 18, 2011
March 10, 2017
December 2010
November 2016   (Final data collection date for primary outcome measure)
  • patient reported nasal obstruction [ Time Frame: 1 week ]
    assessed by a 10-point visual analogue scale (VAS) and Sino Nasal Outcome Score(SNOT-20) questionnaire.
  • objective nasal obstruction [ Time Frame: 1 week ]
    measured by acoustical rhinometry and Peak Nasal Inspiratory Flow (PNIF).
Peak Nasal Inspiratory Flow measured in litres per minute [ Time Frame: 3 months after surgery ]
Complete list of historical versions of study NCT01282125 on ClinicalTrials.gov Archive Site
Not Provided
VAS scale, the subjects will put a mark at a 10 cm line, where 0 defines no subjective discomfort and 10 defines the maximum subjective discomfort [ Time Frame: 3 months after surgery ]
Not Provided
Not Provided
 
Nasal Obstruction in Sleep Apnea Patients Compared to the General Population
A Comparative Study of Nasal Obstruction in a Sleep Apnea Population Compared to the General Population

Recent clinical findings of research at Trondheim University Hospital suggest that surgical correction of the nose septum in addition to volume reduction of the nose cavity may be beneficial in patients who suffer from both nose obstruction and obstructive sleep apnea syndrome(data not yet published).

This study aims to compare nose obstruction prevalence in sleep apnea patients and the general population
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients: St Olavs Hospital, Trondheim, Norway Controls: Community sample, residents of Trøndelag, Norway
  • Obstructive Sleep Apnoea Syndrome
  • Nasal Obstruction
Not Provided
  • sleep apnea
    100 patients suffering from obstructive sleep apnea syndrome
  • controls
    100 subjects matching cases to age, sex, and body weight
Moxness MH, Bugten V, Thorstensen WM, Nordgård S, Bruskeland G. A comparison of minimal cross sectional areas, nasal volumes and peak nasal inspiratory flow between patients with obstructive sleep apnea and healthy controls. Rhinology. 2016 Dec 1;54(4):342-347. doi: 10.4193/Rhin16.085.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
217
November 2016
November 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • ???

Exclusion Criteria:

  • ???
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01282125
OSAS og nasalstenose
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Sorlandet Hospital HF
Principal Investigator: Ståle S. Nordgård, MD PhD Aleris/NTNU
Norwegian University of Science and Technology
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP